Differential effects of olanzapine at dopamine D1 and D2 receptors in dopamine depleted animals

Psychopharmacology

Volumn 142, Issue 2, 1999, Pages 175-181

  Ninan, Ipe ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Dopamine D1; Dopamine D2 receptor; Olanzapine; Partial agonist; Receptor; SKF 38393

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; OLANZAPINE; PIMOZIDE; RITANSERIN; SCOPOLAMINE;

AGONIST; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; DOSE RESPONSE; DRUG EFFECT; DRUG RECEPTOR BINDING; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BENZODIAZEPINES; BRAIN; DOPAMINE; MALE; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; PIRENZEPINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RESERPINE; SEROTONIN UPTAKE INHIBITORS; TYROSINE 3-MONOOXYGENASE;

EID: 0032904935     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050877     Document Type: Article

References (32)

1. 2 receptor affinities in vitro. J Neural Transm 67:225-240
2. 2 agonist quinpirole facilitate the expression of oral stereotyped behavior in rats. Eur J Pharmacol 133:137-145
3. 2 dopamine receptor interactions. Eur J Pharmacol 123:109-114
4. Beasley CM, Tollefson GD, Tran P, Satterlee W, Sanger T, Hilman S and the Olanzapine HGAD Study Group (1996) Olanzapine versus placebo and haloperidol: acute phase results of the North American double blind olanzapine trial. Neuropsychopharmacology 14:111-123
5. Benvenga MJ, Leander JD (1996) Olanzapine increases rates of punished responding in pigeons. Psychopharmacology 119: 133-138
6. Bymaster FP, Calligaro DO, Falcone JF, Marsh RD, Moore NA, Tye NC, Seeman P, Wong DT (1996) Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 14:87-96
7. Chiodo LA, Bunney BS (1983) Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons. J Neurosci 3: 1607-1619
8. Chipkin RE, Latranyi MB (1987) Similarity of clozapine and SCH 23390 in reserpinized rats suggests common mechanism of action. Eur J Pharmacol 136:371-375
9. Costall B, Naylor RJ (1973) On the mode of action of apomorphine. Eur J Pharmacol 21:350-361
10. Costall B, Naylor RJ (1977) Mesolimbic and extrapyramidal sites for the mediation of stereotyped behavior patterns and hyperactivity by amphetamine and apomorphine in the rat. Adv Behav Biol 21:47-76
11. 2 dopamine receptor-mediated behaviours. Eur J Pharmacol 159:141-147
12. 2-like" agonist RU 24213. Psychopharmacology 124:40-49
13. 2 receptors in the effects of the classical neuroleptic haloperidol and the atypical neuroleptic clozapine. Eur J Pharmacol 196:103-108
14. Fuller RW, Snoddy HD (1992) Neuroendocrine evidence for antagonism of serotonin and dopamine receptors by olanzapine. an antipsychotic drug candidate. Res Commun Chem Pathol Pharmacol 77:87-93
15. 1 dopamine receptors are stimulated with SKF 38393. Psychopharmacology 90:147-149
16. 1 receptor agonist. Eur J Pharmacol 282:137-144
17. 2 receptors? Psychopharmacology 138:213-214
18. Meltzer HY, Fibiger HC(1996) Olanzapine: a new atypical antipsychotic drug. Neuropsychopharmacology 14:83-85
19. Moore NA, Tye NC, Axton MS, Risius FC (1992) The behavioral pharmacology of olanzapine a novel "atypical" antipsychotic agent. J Pharmacol Exp Ther 262:545-551
20. Moore NA, Calligaro DO, Wong DT, Bymaster FP, Tye NC (1993) The pharmacology of olanzapine and other new antipsychotic agents. Curr Opin Invest Drugs 2:181-293
21. Moore NA, Rees G, Sanger G, Tye NC (1994) Effect of olanzapine and other antipsychotic agents on responding maintained by a conflict schedule. Behav Pharmacol 5:196-202
22. 2 receptors in dopamine depleted animals. Psychopharmacology 135:311-317
23. 2 receptors! Psychopharmacology 138:215-216
24. Ninan I, Kulkarni SK (1998c) Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801. Ind J Physiol Pharmacol 42:375-382
25. Radhakishun FS, Van Ree JM (1987) The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens. Eur J Pharmacol 136:41-47
26. Reus VI (1997) Olanzapine: a novel atypical neuroleptic agent. Lancet 349:1264-1265
27. 1 receptor agonist. Eur J Pharmacol 307:27-31
28. 2 receptors in the regulation of body temperature in the rat. Eur J Pharmacol 236:395-400
29. Salmi P, Karlsson T, Ahlenius S (1994) Antagonism of SCH 23390 of clozapine-induced hypothermia in the rat. Eur J Pharmacol 253:67-73
30. Stockton ME, Rasmussen K (1996) Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A9 and A10 dopamine neurons. Neuropsychopharmacology 14:92-104
31. 2 dopaminergic actions of B-HT 920 in mice. Ind J Exp Biol 29:123-126
32. Verma A, Kulkarni SK (1993) Differential role of dopamine receptor subtypes in thermoregulation and stereotypic behavior in naive and reserpinized rats. Arch Int Pharmacodyn 324:17-32